AI-Summary – News For Tomorrow
Acting CDC Director Jim O’Neill urged vaccine manufacturers to create separate vaccines for measles, mumps, and rubella, moving away from the combined MMR vaccine. This call followed his approval of a recommendation against administering the combined MMRV vaccine to children under four. Instead, he supports separate MMR and varicella (chickenpox) vaccinations for that age group. Currently, according to the FDA, no single measles, mumps, or rubella vaccines are licensed in the United States.
News summary provided by Gemini AI.
(Reuters) -The acting director of the CDC, Jim O’Neill, in an X post on Monday called on vaccine manufacturers to develop three separate monovalent vaccines to replace the combined measles-mumps-rubella vaccine.
This comes hours after O’Neill signed off on a vaccine advisory panel’s recommendation against the use of a combined measles-mumps-rubella-varicella vaccine before the age of 4 years.
Instead, shots will be given for measles-mumps-rubella with a separate vaccine for varicella, commonly known as chickenpox.
Advertisement
Advertisement
According to the U.S. Food and Drug Administration’s website there are currently no monovalent measles, mumps or rubella vaccines licensed for use in the United States.
(Reporting by Mariam Sunny and Christy Santhosh in Bengaluru; Editing by Shailesh Kuber)
